Schedules of Controlled Substances: Placement of Butonitazene, Flunitazene, and Metodesnitazene Substances in Schedule I
The scheduling of novel synthetic opioids such as butonitazene, flunitazene, and metodesnitazene in Schedule I highlights their high abuse potential. This regulatory update aids clinicians in recognizing these substances with no accepted medical use.…
Schedules of Controlled Substances: Placement of Etodesnitazene, N-Pyrrolidino etonitazene, and Protonitazene in Schedule I
The schedules of controlled substances placement by the DEA now include etodesnitazene, N-pyrrolidino etonitazene, and protonitazene in Schedule I. These synthetic opioid analogs have high abuse potential and no accepted medical use. Clinicians should be…
Understanding Firearms Regulatory Guidance in the Cannabis Context
Firearms regulatory guidance cannabis issues present complex challenges for clinicians. Understanding the legal conflicts between federal firearms laws and state cannabis regulations is essential. This guidance helps ensure patient safety and proper…
Clinical Implications of Marijuana Rescheduling
Marijuana rescheduling clinical implications are significant for research and medical practice. Rescheduling to Schedule III reduces barriers for clinical studies and may improve patient access. Clinicians should stay informed about evolving regulations…
Someones gotta do it!
Someone has to conduct the rigorous clinical trials, and it turns out that responsibility comes with surprisingly thorough documentation requirements. The peer review process is significantly less forgiving than most institutional review boards. Via…
Texas Hemp Businesses Fear More Police Raids Amid Regulatory Uncertainty
Texas hemp police raids have increased, causing disruptions for businesses and patients relying on legal cannabis products. These enforcement actions create uncertainty in the hemp market and affect product availability. Clinicians should be aware of…
Proof Launches California’s First 100% Legal Cannabis Pet Product
Cannabis pet products safety is increasingly important as legal, pharmaceutical-grade options enter the market. Clinicians should understand the regulatory status and evidence base for these products. This knowledge helps guide pet owners on safe…
Legal and Health Implications of Teen THC Crash Sentencing
This article discusses teen THC crash sentencing and the severe consequences of impaired driving among adolescents. It highlights the legal and health risks associated with cannabis use in young drivers. Clinicians should counsel teens on these dangers…
Gov. Beshear Announces Medical Cannabis Updates and Scam Prevention
Kentucky medical cannabis regulations now include a new scam prevention program to protect patients from fraudulent products. Clinicians must understand these regulations to guide patients safely. This ensures patients access legitimate cannabis through…
New Research on CBD and CBG for Fatty Liver Disease
Emerging research on cbd and cbg fatty liver disease shows potential therapeutic benefits beyond lifestyle modification. These non-intoxicating cannabis compounds may reduce liver fat and improve hepatic health. While promising, clinical trials are…